arrow
I

Ian Lee

Henry Ford Health
H指数:30
被引数:4,176

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SADA-17 SURVIVAL AND LOCAL CONTROL AFTER RESECTION AND GAMMATILE BRACHYTHERAPY FOR NEWLY DIAGNOSED BRAIN METASTASES: A PROSPECTIVE REGISTRY ANALYSIS

SADA-17 新诊断脑转移瘤切除联合伽马瓦片近距离放疗后的生存率与局部控制:一项前瞻性登记分析

2026-08-070
OA
INTEGRATIVE MODELING OF EPIGENETIC AND MRI FEATURES IN MENINGIOMA PROGNOSTICATION

表观遗传和MRI特征在脑膜瘤预后判断中的整合建模

2025-11-010
OAAI
Pathologic Incidence of Tumor Positivity Versus Necrosis After Prior Radiotherapy in Patients Undergoing Craniotomy and Resection for Presumed Recurrent Brain Metastasis: Insights from a Prospective Multi-Institutional Registry
2025-04-010
PRE
RECURRENT BRAIN METASTASES (RBM) TREATED WITH SURGICALLY TARGETED RADIATION THERAPY (START): PRELIMINARY SAFETY EVALUATION FROM A MULTI-INSTITUTIONAL PROSPECTIVE REGISTRY
2024-11-110
PRE
EARLY SAFETY DATA FROM A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY, VERSUS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
2024-11-110
PRE
TRIALS IN PROGRESS: REGISTRY OF SAFETY & EFFICACY IN ADULTS WITH PRIMARY & METASTATIC INTRACRANIAL TUMORS TREATED WITH START (GAMMATILES (CS-131 SOURCE BRACHY-THERAPY)): NCT04427384
2024-11-110
PRE
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients
2023-12-078
OA
Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas
2023-09-1314
OAAI